These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10974414)

  • 1. Transplant atherosclerosis: role of phenotypic modulation of vascular smooth muscle by nitric oxide.
    Bundy RE; Marczin N; Birks EF; Chester AH; Yacoub MH
    Gen Pharmacol; 2000 Feb; 34(2):73-84. PubMed ID: 10974414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
    Rudijanto A
    Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
    Weis M; Cooke JP
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide--cyclic GMP pathway regulates vascular smooth muscle cell phenotypic modulation: implications in vascular diseases.
    Lincoln TM; Dey NB; Boerth NJ; Cornwell TL; Soff GA
    Acta Physiol Scand; 1998 Dec; 164(4):507-15. PubMed ID: 9887973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle cell in atherosclerosis.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Acta Physiol (Oxf); 2015 May; 214(1):33-50. PubMed ID: 25677529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Mobility Group Box 1 Mediates Interferon-γ-Induced Phenotypic Modulation of Vascular Smooth Muscle Cells.
    Wang K; Li W; Yu Q; Guo B; Yang B; Zhang C; Li M; Li J; Hu S; Zheng Q; Song Z
    J Cell Biochem; 2017 Mar; 118(3):518-529. PubMed ID: 27579780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
    Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
    J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit.
    Kuwahara M; Jacobsson J; Kuwahara M; Kagan E; Ramwell PW; Foegh ML
    Transplantation; 1991 Nov; 52(5):759-65. PubMed ID: 1949159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
    Wang J; Yan CH; Li Y; Xu K; Tian XX; Peng CF; Tao J; Sun MY; Han YL
    Exp Cell Res; 2013 May; 319(8):1165-75. PubMed ID: 23518389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology.
    Drexler H; Fischell TA; Pinto FJ; Chenzbraun A; Botas J; Cooke JP; Alderman EL
    Circulation; 1994 Apr; 89(4):1615-23. PubMed ID: 8149529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant vascular disease: role of lipids and proteoglycans.
    Rahmani M; McDonald PC; Wong BW; McManus BM
    Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant atherosclerosis: the clinical syndrome, pathogenesis and possible model of spontaneous atherosclerosis.
    Fyfe AI
    Can J Cardiol; 1992 Jun; 8(5):509-19. PubMed ID: 1319812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.
    Zhang MJ; Zhou Y; Chen L; Wang YQ; Wang X; Pi Y; Gao CY; Li JC; Zhang LL
    Histochem Cell Biol; 2016 Feb; 145(2):119-30. PubMed ID: 26708152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.
    Kibbe MR; Li J; Nie S; Watkins SC; Lizonova A; Kovesdi I; Simmons RL; Billiar TR; Tzeng E
    J Vasc Surg; 2000 Jun; 31(6):1214-28. PubMed ID: 10842159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.